Literature DB >> 8094799

Ganciclovir for chronic active Epstein-Barr virus infection.

Y Ishida, Y Yokota, H Tauchi, M Fukuda, T Takaoka, M Hayashi, H Matsuda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8094799     DOI： 10.1016/0140-6736(93)90323-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Sequential quantification of Epstein-Barr virus DNA in a case of Epstein-Barr virus-associated hemophagocytic syndrome.

Authors:  Toru Takahashi; Eiichi Oeda; Yutaka Sato; Yukio Tanizawa
Journal:  Int J Hematol       Date:  2002-10       Impact factor: 2.490

2.  Randomised trial of ganciclovir and acyclovir in the treatment of herpes simplex dendritic keratitis: a multicentre study.

Authors:  H B Hoh; C Hurley; C Claoue; M Viswalingham; D L Easty; P Goldschmidt; L M Collum
Journal:  Br J Ophthalmol       Date:  1996-02       Impact factor: 4.638

3.  Budd-Chiari syndrome and Epstein-Barr virus (EBV) associated plasmacytoma in a patient with chronic active EBV infection.

Authors:  S Nagafuchi; H Ishibashi; K Anzai; K Ohshima; Y Ohno; N Fukushima; M Hashizume; K Sugimachi; H Chuman; M Kikuchi
Journal:  Clin Investig       Date:  1994-11

4.  Clinical effects of infusing anti-Epstein-Barr virus (EBV)-specific cytotoxic T-lymphocytes into patients with severe chronic active EBV infection.

Authors:  Masao Hagihara; Takahide Tsuchiya; Osamu Hyodo; Yoko Ueda; Kei Tazume; Aya Masui; Ayako Kanemura; Fumiaki Yoshiba; Shinji Takashimizu; Shohei Matzusaki; Shunichi Kato; Tomomitsu Hotta
Journal:  Int J Hematol       Date:  2003-07       Impact factor: 2.490

5.  Optimal treatment for chronic active Epstein-Barr virus disease.

Authors:  Jeffrey I Cohen
Journal:  Pediatr Transplant       Date:  2009-06

6.  Interferon alpha as antiviral therapy in chronic active Epstein-Barr virus disease with interstitial pneumonia - case report.

Authors:  Jacek Roliński; Ewelina Grywalska; Aleksandra Pyzik; Michał Dzik; Violetta Opoka-Winiarska; Agata Surdacka; Maciej Maj; Franciszek Burdan; Michał Pirożyński; Piotr Grabarczyk; Elżbieta Starosławska
Journal:  BMC Infect Dis       Date:  2018-04-20       Impact factor: 3.090

7.  Chronic active Epstein-Barr exacerbated by COVID-19 co-infection.

Authors:  David B Villafuerte; Olga Lavrynenko; Rayan Qazi; Marco F Passeri; Fernando L Sanchez
Journal:  Int J Infect Dis       Date:  2022-07-22       Impact factor: 12.074
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.